Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Hirsute women have higher testosterone, cholesterol, and glucose levels.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The method accurately measures hormones and endocannabinoids in mice, showing gut microbiota diversity affects these levels and may influence stress and reproductive systems.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Testosterone raises blood pressure and changes kidney protein levels.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Going to bed late may increase hormones and decrease muscle in women with PCOS.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

CT scans can find serious prostate cancer even when PSA levels are low.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.